Τόμος 22 (2008) – Τεύχος 2 – Άρθρο 34 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – Volume 22 (2008) – Issue 2 – Article 34 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition

1. Deparment of General Biology and 2. Laboratory of Histology – Embryology & Anthropology, Medical School, Aristotle University of Thessaloniki, Greece

pharmakonpress[at]pharmakonpress[.]gr

2. Wyllie A.H., Kerr J.E., Currie A.R.: Cell death: the significance of apoptosis. Int. Rev. Cytol.  68: 251-306 (1980)

3. Cohen G.M.: Caspases: the executioners of apoptosis. Biochem. J. 326: 1-16 (1997)

4. Janicke R.U., Sprengart M.L., Wati M.R., Porter A.G.: Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J. Biol. Chem. 273: 9357-9360 (1988)

5. Sakahira H., Enari M., Nagata S.: Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature 391: 96-99 (1998)

6. Nickolson D.W., Ali A., et al.: Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376: 37-43 (1995)

7. Shiokawa D., Ohyama H., Yamada T., Takahashi K., Tanuma S.: Identification of an endonuclease responsible for apoptosis in rat thymocytes. Eur. J. Biochem. 226: 23-30 (1994)

8. Bajic V., Milicevic Z., Spremo-Potparevic B.: A negative adaptive response is expressed in peripheral blood lymphocytes that are exposed to mitomycin C and cycloheximide. J. BUON  10(1): 111-117 (2005)

9. Satav J.G., Katyare S.S., Fatterparker P., Sreenivasan A.: Study of protein synthesis in rat liver mitochondria use of cycloheximide. Eur. J. Biochem. 73(1): 187-193 (1977)

10. Mullauer L., Mosberger I., Grusch M., Rudas M., Chott A.: Fas ligand is expressed in normal breast epithelial cells and is frequently up-regulated in breast cancer. J. Pathol. 190: 20-30 (2000). Comment in: J. Pathol. 191: 468-470 (2000)

11. Tang D., Lahti J.M., Grenet J., Kidd V.J.: Cycloheximide-induced T-cell death is mediated by a Fas-associated death domain-dependent mechanism J. Biol. Chem. 274: 7245-7252 (1999)

12. Emmanouil-Nikoloussi E.-N., Frangou-Massourides H.: Cycloheximide a protein synthesis inhibitor with teratogenic, embryotoxic and carcinogenetic expression. Aristotle University Medical Journal 34(1): 35-38 (2007)

13. Emmanouil-Nicoloussi E.-N., Frangou H., Nikolousis E., Manthou M.-E., Papamitsou Th., Goula Ch., Massouridou S., Likartsis Ch., Lazaridis Ch, Manthos A.: Enormous rat breast tumor development after cycloheximide treatment during pregnancy. Histochemical and immunohistochemical A, and B estrogen receptor identification. Hell. Med. 73: 335-341 (2007)

14. Nordlie R.C., Lardy H.A.: Subcellular distribution of rat liver PPiase activity. Biochim. Biophys. Acta 50: 189-191 (1961)

15. Bradford M.: A rapid and sensitive method for the quantitation of microgram quantities of protein using the principle of protein-dye binding. Anal. Biochem. 72: 248-254 (1976)

16. Bearden J.C.: Quantitation of submicrogram quantities of protein by an improved protein-dye binding assay. Biochim. Biophys. Acta 533: 525-529 (1978)  

17. Kistler A.: Teratogenesis of retinoic acid in rats: susceptible stages and suppression of retinoic acid-induced limb malformations by cycloheximide. Teratology 23(1): 25-31 (1981)

18. Courchesne C.L., Bantle J.A.: Analysis of the activity of DNA, RNA, and protein synthesis inhibitors on Xenopus embryo development. Teratog. Carcinog. Mutagen 5: 177-193 (1985)

19. Tsuchida T., Kato T., Yamada A., Kawamoto K.: Cycloheximide induces apoptosis of astrocytes. Pathol. Int. 52: 181-185 (2002)

20. Yu A.C, Yung H.W., Hui M.H., Lau L.T., Chen X.Q., Collins R.A.: Cycloheximide and actinomycin D delay death and affect bcl-2, bax, and lce gene expression in astrocytes under in vitro ischemia. J. Neurosci. Res. 74: 318-325 (2003)

pharmakonpress[at]pharmakonpress[.]gr

pharmakonpress[at]pharmakonpress[.]gr